Skip to content
October 4, 2023
  • Facebook
  • Twitter
  • YouTube
  • Instagram
  • Reddit
  • Telegram
  • TikTok
  • LinkedIn
  • Discord
Orinoco Tribune – News and opinion pieces about Venezuela and beyond

Orinoco Tribune – News and opinion pieces about Venezuela and beyond

From Venezuela and made by Venezuelan Chavistas

Primary Menu
  • News
  • Opinion
  • About us
    • About us
    • Who we are – Becoming a Volunteer
    • Editorial guidelines for contributors
    • Our Sources
      • Venezuelan Sources
      • International Sources
    • Contact us
  • Categories
    • Politics
    • Economy
    • Security and Defense
    • International
      • Africa
      • Asia
      • Europe
      • Oceania
      • US/Canada
    • Latin America and ALBA-TCP
      • South America
      • Central America and the Caribbean (+Mexico)
    • Ideology-Commune-Labor
    • Health-Education-Sport-Culture-Technology
    • Solidarity and Social Movements
    • OT Specials
  • Support Us
Light/Dark Button
YouTube Channel
  • Home
  • News
  • Second AstraZeneca Volunteer Reportedly Suffers Rare Neurological Condition, but UK Company Says it’s not Related to Vaccine
  • Europe
  • International
  • News

Second AstraZeneca Volunteer Reportedly Suffers Rare Neurological Condition, but UK Company Says it’s not Related to Vaccine

September 21, 2020

September 20, 2020.- Two people have fallen ill during the trials of AstraZeneca’s coronavirus vaccine in the UK, the company’s internal papers revealed, and a source said they had both suffered from the same serious neurological disorder.

The company published details of the trials on Saturday, after facing criticism over the lack of transparency surrounding the testing of the much-anticipated vaccine against the virus, which has so far infected more than 30.8 million people and caused over 958,000 fatalities worldwide.

The first participant of the British trials – which are being conducted in conjunction with Oxford University – fell ill after receiving one dose of the experimental vaccine in July.

The female volunteer was later diagnosed with transverse myelitis, a rare inflammatory disease that affects the spinal cord, causing weakness, sensory alterations, and autonomic nervous-system dysfunction. The company’s spokeswoman later told the media the volunteer had undiagnosed multiple sclerosis, and the trials resumed.

RELATED CONTENT: Latin America Looking Towards Russia and China Amid US Operation Warp Speed

The second female recipient of the vaccine suffered complications after the follow-up dose in September. AstraZeneca didn’t confirm her diagnosis, but a source told the New York Times it was also transverse myelitis.

On September 6, trials of the drug were paused again, after the second woman felt ill, but they resumed in Britain, Brazil, India, and South Africa less than a week later. The US hasn’t yet green-lighted the continuation of the test, however.

AstraZeneca, which has administered its vaccine to some 18,000 people worldwide, said in internal documents that the two cases of the illness were “unlikely to be associated with the vaccine, or there was insufficient evidence to say for certain that the illnesses were or were not related to the vaccine.”

Transverse myelitis is a serious and rare disease, and its repeated cases among the participants of the trials may well see AstraZeneca losing its vaccine bid all together.

AstraZeneca’s vaccine uses a monkey adenovirus that shares a gene with the Covid-19 coronavirus. It’s an untested method of vaccine development, according to Kirill Dmitriev, CEO of the Russian Direct Investment Fund that bankrolled the Russian vaccine development.

RELATED CONTENT: According to Oxfam, Rich Countries Have Already Hoarded Most Future COVID Vaccines

Unlike AstraZeneca’s jab, Russia’s Sputnik V, the world’s first registered vaccine, uses human adenoviruses as a vector – an extensively studied approach.

Earlier this month, respected British medical journal The Lancet published the Russian Ministry of Health’s Sputnik V study, showing the vaccine to be 100 percent effective, producing antibodies in all 76 participants of early-stage trials.

 

Featured image: © Reuters / Siphiwe Sibeko

(RT)

Don't want to be a victim of the Algorithm?

SIGN UP TO RECEIVE OUR WEEKLY DIGEST WITH ALL YOU NEED TO KNOW ABOUT VENEZUELA AND BEYOND

We don’t spam! Read our privacy policy for more info.

orinocotribune
Website | + posts
  • orinocotribune
    https://orinocotribune.com/author/orinocotribune/
    Projection screen at a National Primaries Commission press conference in a room with empty chairs. Photo: Miguel Gutiérrez/EFE/File photo.
    October 2, 2023
    Venezuela: Opposition Primary Commission Refuses to Modify Election Date
  • orinocotribune
    https://orinocotribune.com/author/orinocotribune/
    Venezuelan President Hugo Chavez (left) and then student leader Robert Serra (right), during a political rally. Photo: AFP/File photo.
    October 2, 2023
    Venezuela's Youth Commemorate 9th Anniversary of Robert Serra's Assassination
  • orinocotribune
    https://orinocotribune.com/author/orinocotribune/
    Poster for Orinoco Tribune's special interview with US academic Steve Ellner. Photo: Orinoco Tribune.
    October 1, 2023
    US Academic Steve Ellner: Venezuela Needs More Checks and Balances to Fight Corruption and Abuse of Power
  • orinocotribune
    https://orinocotribune.com/author/orinocotribune/
    Palestinian President Mahmud Abbas (left) receiving the credentials of Nayef al-Sudairi(right), Saudi Arabia's non-resident ambassador to Palestine. Photo: Thaer Ghanaim/PPO/AFP.
    October 1, 2023
    Saudi Arabia is Trying to Pacify Palestinians While Opening the Gates of Normalization With Israel
Tags: AstraZeneca coronavirus COVID-19 UK Vaccine

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to share on Reddit (Opens in new window)
  • Click to share on Telegram (Opens in new window)
  • Click to email a link to a friend (Opens in new window)

Continue Reading

Previous Previous post:

“Smells Like Sulfur”: 14 Years After Commander Chavez’s Historic UN Speech

Next Next post:

Abolish the Supreme Court, Senate and the Electoral College

Subscribe to Weekly Digest

We keep your data private and share your data only with third parties that make this service possible. Read our Privacy Policy.

Check your inbox or spam folder to confirm your subscription.

NEWS: MOST POPULAR

Calendar

October 2023
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
« Sep    

Categories

OPINION: MOST POPULAR

We are on Telegram


Receive our news directly in your cell phone or PC, join us on our TELEGRAM channel.

 

We are on Discord


Join our Discord server to check our content without algorithms and to interact directly with our team.

The original content by Orinoco Tribune is free to share and it is licensed under CC BY 4.0

We are on Reddit

If you are more into REDDIT, join our Orinoco Tribune subreddit.

  • Facebook
  • Twitter
  • YouTube
  • Instagram
  • Reddit
  • Telegram
  • TikTok
  • LinkedIn
  • Discord
Copyleft, No rights reserved.

W E    N E E D    Y O U R    S U P P O R T

Orinoco Tribune operates without any advertising. We are not funded by any governments, think tanks, or large institutions. Our operations are entirely funded by readers like you. Our most generous donors have been targeted by the US for supporting socialist causes or are financially struggling. As a result, their accounts have been frozen, cutting off a significant revenue stream and severely threatening the sustainability of Orinoco Tribune.

We urge our readers and supporters, especially those not currently doing so, to help us with small donation (such as US $5 or $10/month) via Patreon, via Paypal/Credit-Card/crypto or via paper checks. Readers and supporters like you will allow us to continue bringing you progressive and hard-hitting news from Latin America, the Global South, and the world.

Help us reach our goal of $650 in monthly Patreon donations. We are counting on you as our only source of financial support!